Research Article

Characteristics, Management, and Outcomes of Community-Acquired Pneumonia Due to Human Rhinovirus—A Retrospective Study

Table 1

Characteristics of patients admitted with rhinovirus pneumonia.

VariableAll patients
N = 106
ICU admission
N = 16
No ICU admission
N = 90
value

Age (years), median (Q1, Q3)71.5 (44.0, 84.0)69.0 (47.0, 82.8)72.0 (43.8, 84.0)0.81
Male gender, N (%)50 (47.2)6 (37.5)44 (48.9)0.40
BMI (kg/m2), median (Q1, Q3)27.3 (22.7, 35.04)30.3 (23.0, 40.0)27.0 (22.7, 34.3)0.27
Smoking, N (%)8 (7.5)2 (12.5)6 (6.7)0.42
Comorbidities, N (%)
 Diabetes53 (50.0)8 (50.0)8 (50.0)8 (50.0)
 Hypertension62 (59.0)11 (68.8)51 (57.3)0.39
 Hypothyroidism16 (15.1)3 (18.8)13 (14.4)0.66
 Heart failure37 (34.9)8 (50.0)29 (32.2)0.17
 Cerebrovascular accident20 (18.9)2 (12.5)18 (20.0)0.48
 Chronic kidney disease22 (20.8)2 (12.5)20 (22.2)0.38
 Dialysis8 (7.5)0 (0)8 (8.9)0.22
 Ischemic heart disease22 (20.8)6 (37.5)16 (17.8)0.07
 Dyslipidemia27 (25.5)3 (18.8)24 (26.7)0.50
 Chronic respiratory disease47 (44.3)10 (62.5)37 (41.1)0.40
 Liver disease3 (2.8)1 (6.3)2 (2.2)0.37
 Immunosuppression9 (8.5)3 (18.8)6 (6.7)0.11
 Malignancy6 (5.7)2 (12.5)4 (4.4)0.20
 Transplant3 (2.8)1 (6.3)2 (2.2)0.37
Bedbound before hospitalization, N (%)28 (26.4)2 (12.5)26 (28.9)0.17
Presenting symptoms, N (%)
 Fever41 (38.7)5 (31.3)36 (40.0)0.51
 RR > 30/min34 (32.1)10 (62.5)24 (26.7)0.005
 Systolic BP < 90 mm Hg9 (8.5)3 (18.8)6 (6.7)0.11
T < 35 or >39.9°C11 (10.4)0 (0)11 (12.2)0.14
 Pulse >125/min20 (18.9)5 (31.3)15 (16.7)0.17
 Shortness of breath96 (90.6)16 (100)80 (88.9)0.16
 Dry cough25 (23.6)5 (31.3)20 (22.2)0.43
 Purulent cough66 (62.2)7 (43.8)59 (65.5)0.24
 Chest pain16 (15.1)2 (12.5)14 (15.6)0.75
 Myalgia/arthralgia23 (21.7)1 (6.3)22 (24.4)0.10
 Fatigue27 (25.5)3 (18.8)24 (26.7)0.50
 Headache11 (10.4)0 (0)11 (12.2)0.14
 Hemoptysis2 (1.9)2 (12.5)0 (0)0.001
Pneumonia severity index, median (Q1, Q3)107.0 (78.5, 129.8)116.5 (91.0, 142.5)105.0 (73.3, 128.8)0.29
Laboratory findings, median (Q1, Q3)10.95 (7.92, 14.13)11.30 (8.32, 14.58)10.95 (7.90, 14.10)0.58
 White blood cell (109/L)74.4 (62.0, 81.90)86.4 (77.0, 91.7)74.0 (61.03, 80.0)0.02
 Neutrophil %13.1 (9.28, 22.60)5.7 (3.40, 9.70)13.9 (10.0, 24.5)0.01
 Lymphocyte %0.37 (0.32, 0.42)0.31 (0.26, 0.39)0.38 (0.33, 0.43)0.006
 Hematocrit30.1 (26.8, 32.1)30.9 (28.9, 34.0)30.0 (26.7, 33.0)0.19
 PTT (seconds)1.1 (1.1, 1.3)1.2 (1.1, 1.5)1.1 (1.1, 1.2)0.11
 INR38 (35.8)4 (25.0)34 (37.8)0.33
 BUN >11 mmol/L, N (%)136 (133, 139)136 (135, 137.75)136 (133, 139)0.82
 Sodium (meq/L)88.0 (65.0, 136.0)87.0 (83.3, 135.8)88.0 (64.0, 136.0)0.76
 Creatinine (μmol/L)1.7 (1.3, 2.7)2.0 (1.6, 4.2)1.6 (1.2, 2.6)0.47
 Lactic acid (mmol/L) pH7.36 (7.30, 7.40)7.38 (7.34, 7.44)7.35 (7.30, 7.40)0.14
 PaO2 (mm Hg)73.0 (61.2, 82.0)78.3 (62.0, 122.3)70.6 (59.0, 79.6)0.12
Leukocytosis (white blood cell> 15.00 109/L, N (%)20 (18.9)3 (18.8)17 (18.9)1.0
Lymphopenia (<1000 × 106/L), N (%)26/87 (29.9)5/7 (71.4)21/80 (26.3)0.01
Neutrophil-to-lymphocyte ratio, median (Q1, Q3)5.9 (3.1, 8.4)10.4 (6.0, 18.5)5.2 (2.7, 8.0)0.02
C-reactive protein (mg/L), median (Q1, Q3)42.5 (23.0, 108.0)30.2 (9.0, 72.0)49.5 (23.0, 116.5)0.38
C-reactive protein> 40 mg/L, N (%)24/45 (53.3)3/7 (42.9)21/38 (55.3)0.69
Procalcitonin (ng/ml), median (Q1, Q3)0.10 (0.05, 0.56)0.41 (0.12, 0.58)0.08 (0.04, 0.56)0.35
Procalcitonin> 0.5 ng/ml, N (%)9/31 (29.0)2/4 (50.0)7/27 (25.9)0.56
Bacterial coinfection, N (%)7 (6.6)6 (6.7)1 (6.3)1.0
Chest X-ray findings
 Unilateral infiltrates26/101 (25.7)5/16 (31.3)21/85 (24.7)0.55
 Bilateral infiltrates47/101 (46/5)11/16 (68.8)36/85 (42.4)0.06
 Unilateral pleural effusion22/101 (21.8)3/16 (18.8)19/85 (22.4)1.0
 Bilateral pleural effusion16/101 (15.8)3/16 (18.8)13/85 (15.3)0.71
Chest computed tomography findings
 Unilateral infiltrates6/20 (30)2/6 (33)4/14 (28.6)1.0
 Bilateral infiltrates7/20 (35)3/6 (50)4/14 (28.6)0.61
 Unilateral pleural effusion2/20 (10)1/6 (16.7)1/14 (7.1)0.52
 Bilateral pleural effusion4/20 (20)2/6 (33.3)2/14 (14.3)0.55

BMI: body mass index, BP: blood pressure, BUN: blood urea nitrogen, ICU: intensive care unit, INR: international normalized ratio PTT: partial thromboplastin time, Q1: first quartile, Q3: third quartile, RR: respiratory rate, and T: body temperature. Complete data to calculate PSI was available in only 42 patients. C-reactive protein level within 2 days of admission was available in 45 patients. Procalcitonin level within 2 days of admission was available in 31 patients. Data were missing for some patients. The denominator represents the number of patients with available data.